Ibn Sina Pharma Considers Incentives

The Extraordinary General Assembly of Ibnsina Pharma will discuss on September 1, 2026, the approval of a reward and incentive system for the executive directors and members of the board of directors through a promise of sale, based on a study and approval by the board of directors. The discussions include determining the number of shares allocated, methods of financing their issuance or purchase, and authorizing the board of directors to issue shares and carry out the necessary procedures to obtain approval for the system from the Financial Regulatory Authority. The objective of the system is to motivate the managers and enhance the company's performance.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل